Drug R&D

Pharma AI readiness: Which companies are leading the AI charge?

Pharma AI readiness: Which companies are leading the AI charge?

Our data-driven analysis reveals how major pharma companies stack up across key AI readiness metrics, from technical partnerships to organizational culture.

Jul 3, 2025

The AI in drug R&D market map

The AI in drug R&D market map

We map out 200+ companies applying AI to discover and develop new therapeutics, from project inception through commercialization.

May 23, 2025

Inside Novo Nordisk’s $33B manufacturing push to strengthen its obesity portfolio and build a biologics powerhouse

Inside Novo Nordisk’s $33B manufacturing push to strengthen its obesity portfolio and build a biologics powerhouse

We mined Novo Nordisk’s acquisitions, investments, and partnerships to discern its strategic priorities and future plans.

Apr 25, 2025

State of Digital Health Q1’25 Report

State of Digital Health Q1’25 Report

Digital health roared into 2025, with funding, M&A, and unicorn births all hitting multi-year highs. We break down the data and trends driving this rebound — from AI’s growing dominance in dealmaking to the return of billion-dollar exits — using CB Insights data.

Apr 17, 2025

AI in Pharma: The New Playbook for Drug Research & Development

Webinar Apr 10 11 AM EDT

AI in Pharma: The New Playbook for Drug Research & Development

In this webinar, our expert breaks down AI’s impact across the entire R&D pipeline – from discovery to FDA approval.

Get the recording

Apr 10, 2025

7 tech M&A predictions for 2025

7 tech M&A predictions for 2025

AI will be the driving force behind tech M&A deals in 2025. From AI agent consolidation to big tech’s next battlefield, we highlight 7 areas where we expect to see deals this year.

Mar 21, 2025

AI in clinical trials: How the tech is serving pharma’s riskiest bet

AI in clinical trials: How the tech is serving pharma’s riskiest bet

From deal activity to top investors, we analyze the shifting landscape for AI in clinical trials to determine how the tech is transforming drug development for the better.

Mar 17, 2025

The generative AI in healthcare and life sciences market map

The generative AI in healthcare and life sciences market map

From clinical operations to drug development, we mapped 85+ startups bringing generative AI to the healthcare and life sciences industries.

Mar 11, 2025

State of Digital Health 2024 Report

State of Digital Health 2024 Report

From AI’s ascendance to cautious dealmaking, we break down the trends reshaping digital health in 2024 using CB Insights data.

Jan 16, 2025

AI’s moment in preclinical drug development arrives: Why formulation tech is the next frontier

AI’s moment in preclinical drug development arrives: Why formulation tech is the next frontier

AI promises to accelerate the path from bench to bedside. Using CB Insights data, we highlight emerging markets in the preclinical phase that are ripe for pharma investments and partnerships.

Jan 3, 2025

Inside the AI drug discovery arms race: Record M&A activity, a biologics funding spree, and more

Inside the AI drug discovery arms race: Record M&A activity, a biologics funding spree, and more

We analyze funding and acquisitions data, clinical progress, and partnership strategies to help pharma companies and investors navigate the maturing AI landscape in drug discovery.

Dec 11, 2024

Roche targets two emerging battlegrounds — obesity and AI diagnostics — for its next growth phase

Roche targets two emerging battlegrounds — obesity and AI diagnostics — for its next growth phase

We mined Roche’s acquisitions, investments, and partnerships to discern the company's strategic priorities. Here’s what pharma and diagnostics companies need to pay attention to.

Nov 27, 2024

15 tech trends to watch closely in 2025

15 tech trends to watch closely in 2025

The future of LLMs. Caregiving humanoid robots. Crypto’s baby steps. We use CB Insights data to uncover 15 emerging trends that will shape the tech landscape for years to come.

Nov 19, 2024

Analyzing Eli Lilly’s growth strategy: How the pharma giant is leveraging AI and pioneering a direct-to-patient approach

Analyzing Eli Lilly’s growth strategy: How the pharma giant is leveraging AI and pioneering a direct-to-patient approach

We analyzed Eli Lilly’s tech-focused acquisitions, investments, and partnerships to discern the company’s strategic priorities.

Oct 7, 2024

Prioritizing clinical trials tech: How 16 tech-driven markets stack up across maturity and momentum

Prioritizing clinical trials tech: How 16 tech-driven markets stack up across maturity and momentum

This report uses the CB Insights TECH Framework to rank clinical trials markets based on current commercial readiness and momentum.

Sep 11, 2024

Animal health is seeing new innovations — here’s what early-stage startup activity says about the future of the space

Animal health is seeing new innovations — here’s what early-stage startup activity says about the future of the space

From rapid, on-site diagnostics to novel stem cell therapies, animal health is seeing a wave of innovations to prevent, diagnose, and treat disease.

Sep 6, 2024

Our top digital health research and trends to watch

Our top digital health research and trends to watch

Bet on the right digital health markets. Dig into your rivals’ health tech strategies. Identify the best digital health startups.

Aug 29, 2024

Analyzing a16z’s AI investment strategy: Where the firm sees opportunity amid the genAI rush

Analyzing a16z’s AI investment strategy: Where the firm sees opportunity amid the genAI rush

In 2024 so far, Andreessen Horowitz’s leading AI priorities are multimedia generation and AI-fueled agents & copilots.

Aug 23, 2024

The clinical trials tech market map

The clinical trials tech market map

From protocol design to real-world data, we map the 96 tech companies making clinical trials faster, cheaper, and more patient-centric.

Aug 21, 2024

Digital Health M&A: Every second acquisition in 2024 has been an AI company

Digital Health M&A: Every second acquisition in 2024 has been an AI company

From medical scribes to clinical trial platforms, AI-driven solutions are key targets of digital health M&A deals in 2024 so far. Here’s where we’re seeing the most activity.

Aug 2, 2024

3 supply chain technologies combatting counterfeits of drugs like Ozempic that cost pharma companies billions

3 supply chain technologies combatting counterfeits of drugs like Ozempic that cost pharma companies billions

As concerns mount around the rise of counterfeit drugs, supply chain technologies such as IoT asset tracking, blockchain ledgers, and product & packaging authentication can provide pharma companies with more visibility and supply chain security.

Jul 25, 2024

Analyzing Sanofi’s growth strategy: How the pharma giant is aiming to bring drugs to market faster and address chronic diseases

Analyzing Sanofi’s growth strategy: How the pharma giant is aiming to bring drugs to market faster and address chronic diseases

We mined Sanofi's investments and partnerships to discern the company’s strategic priorities.

Jun 27, 2024

Big Tech in Healthcare: How Amazon, Google, Microsoft, & Nvidia are looking to transform drug R&D, primary care, and more

Big Tech in Healthcare: How Amazon, Google, Microsoft, & Nvidia are looking to transform drug R&D, primary care, and more

Tech leaders are aggressively applying cloud computing and generative AI to tackle issues in healthcare. We look at how 4 tech giants are building their positions in the industry using strategic investments, partnerships, and product launches.

Jun 12, 2024

The quantum information market map: The companies working on quantum computing, post-quantum cryptography, and more

The quantum information market map: The companies working on quantum computing, post-quantum cryptography, and more

From commercializing quantum computer applications in industries like finance and healthcare to defending against quantum algorithms with new post-quantum cryptography standards, the quantum information landscape is rapidly becoming more complex. We break down the tech companies defining the quantum future.

May 7, 2024

AI strategies for 11 of the world’s largest companies: Where Eli Lilly, Visa, Oracle, and 8 other giants are making moves

AI strategies for 11 of the world’s largest companies: Where Eli Lilly, Visa, Oracle, and 8 other giants are making moves

We mined earnings calls, analyzed business relationships, and dug into investments and acquisitions to survey the AI activities of some of the world’s largest companies across industries.

May 2, 2024

More